Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
BBC must change or be ‘a Titanic’, says manager of the Sidemen YouTubers
5/11/2025
Reform’s public-sector pensions plan could cost billions extra, union warns
5/11/2025
Russian forces appear to tighten grip on strategic city of Pokrovsk
5/11/2025
Hindu devotion and a Beaver supermoon : photos of the day – Wednesday
5/11/2025
Archaeologists discover how oldest American civilisation survived a climate catastrophe
5/11/2025
Man gropes Mexico president as she speaks with citizens on the streets
5/11/2025